Top Articles
#1 in Business Subscribe Email Print

You are here: Home > Finance > Investing > Rate Yourself - A 20-Question Scorecard for Stock Investors

Tags

  • combination
  • increase
  • better
  • developing combination
  • developing combination
  • total score

  • Links

  • Fat Burners: The Shocking Truth
  • A Few Facts About Deep Sea Fish Oil
  • Risks Associated With Botox Injections
  • Top Articles - Rate Yourself - A 20-Question Scorecard for Stock Investors

    Are you a good stock investor?

    This Stock Investing Scorecard will help you understand what you do well, plus it will suggest areas where you might pay the most attention to improving your investment practices.

    Score yourself from 0 (worst) to 5 (best)
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    on each of the following. Then check your total score at the end to see where you stand.

    1. I believe that the market is rational over the long term and rewards sensible, intelligent investing. I also recognize that the market is essentially unpredicta
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    ble over very short periods such as a day or a week.

    2. I always maintain a fiduciary duty to myself. I never forget Buffett’s Rule #1: Don’t lose money.

    3. I know my investment goals and have clear strategies to reach them. I have written them out, an
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    d I review them at least once per year. I adjust or amend them when appropriate.

    4. I only invest in excellent companies with sound business models that I understand. I must comprehend how a company makes money before I will invest in it. I will not fal
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    l for the next Enron.

    5. I always determine a rational price for any stock. I only buy at a fair or advantageous price.

    6. I know that a 50% loss on a stock followed by a 100% gain equals zero. Therefore, I am very careful to avoid a large loss on even
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    a single stock.

    7. I manage my portfolio intelligently and consistently. This does not mean that I trade a lot, but it does mean that I pay attention. I keep track of the results of each individual stock investment, and I make strategic decisions about
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    what to keep and what to sell. My goal is to let my winners run and to sell my losers.

    8. I know that any investment in the stock market carries risk. I actively manage that risk. I am willing to tolerate some short-term variability in my wealth in ord
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    r to gain the long-term benefit of beating inflation through stocks. I am not willing to tolerate significant losses.

    9. Before making any move in the market, I do everything I can to stack the odds in my favor. I know that the best results come when I
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    have an edge. The edge can be better information, better analysis, an advantageous price, better risk management, or a combination of all of them.

    10. I read, analyze, and do my own thinking. I am always striving to improve my investment practices. I ne
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ver buy a stock solely on a tip.

    11. Whenever I am interested in a company, I write out its “story” in a few sentences. This includes the company’s business model, its strategies, its prospects for sustainable profits, and (especially) its competitive a
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    dvantages. If I can’t understand the company's business enough to do that, I don’t invest in it.

    12. I only purchase a stock when it is showing strength. I want each of my investments to get off to a good start.

    13. I always look for companies with the
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    best prospects for long-term earnings growth. I know that over the long term, stock prices follow corporate earnings.

    14. I invest only in dominant companies. They have competitive advantages that will enable them to sustain earnings growth.

    15. I nev
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    er trust management which has demonstrated a lack of integrity.

    16. I have fun investing. I don’t overextend myself, and I never put money into companies that make or do anything I don’t admire.

    17. I am wary of companies with excessive debt, because I
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    know that it is as hard for them to handle as it would be for me. The mere fact that other companies in the same industry also carry lots of debt is no excuse, because I know that every company chooses its capital structure. No solid company needs to be
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    over its head in debt.

    18. Although I do not demand that a company pay dividends, I do consider the regular payment and raising of dividends to be a big plus factor.

    19. I run my investments like a business. I am dispassionate when making buy, hold, or
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    sell decisions. I never fall in love with a stock. If it is a loser, I let it go. I do not over-hold any stock just waiting (hoping) for it to get back to even.

    20. If I cannot find good investment opportunities, I am never afraid to have some of my ''
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    stock money'' in cash. I do not feel the need to be ''fully invested'' at all times.

    How did you do? The maximum score is 100. If your score is high, congratulations! You are following a sound approach to investment success.

    If your total score is belo
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    w 80, that raises a serious question whether you should be investing in stocks at all. The good news is that you can improve your knowledge and practices in every area considered.

    Focus on any low-scoring areas. If you gave yourself 0, 1, or 2 on any qu
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    estion, that is definitely a red flag. Concentrate on improving your practices in that area. My experience is that improving in any one area can have a significant impact on your overall success in the stock market.

    Of course, the best investors are goo
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    d across the board. That should be your ultimate goal. Investors sometimes go wrong by skipping essential steps. They make “one-time” exceptions. Don’t do that. Follow best practices, and adhere to your own written strategies and tactics, all of the time


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.toparticles.org.ua/article/102234/toparticles-Rate-Yourself--A-20Question-Scorecard-for-Stock-Investors.html">Rate Yourself - A 20-Question Scorecard for Stock Investors</a>

    BB link (for phorums):
    [url=http://www.toparticles.org.ua/article/102234/toparticles-Rate-Yourself--A-20Question-Scorecard-for-Stock-Investors.html]Rate Yourself - A 20-Question Scorecard for Stock Investors[/url]

    Related Articles:

    Pros and Cons of Six Sigma

    Samples of Resume Cover Letter Do's and Don'ts

    Analyzing Your Traffic Statistics

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com